id | C00002473 |
---|---|
Name | Fraxetin |
CAS RN | 574-84-5 |
Standard InChI | InChI=1S/C10H8O5/c1-14-6-4-5-2-3-7(11)15-10(5)9(13)8(6)12/h2-4,12-13H,1H3 |
Standard InChI (Main Layer) | InChI=1S/C10H8O5/c1-14-6-4-5-2-3-7(11)15-10(5)9(13)8(6)12/h2-4,12-13H,1H3 |
Phytochemical cluster | No. 25 |
---|---|
KCF-S cluster | No. 864 |
By standard InChI | CHEMBL54909 |
---|---|
By standard InChI Main Layer | CHEMBL54909 |
By LinkDB | C09265 |
---|
By CAS RN | C105671 |
---|
class name | count |
---|---|
asterids | 6 |
rosids | 4 |
eudicotyledons | 1 |
family name | count |
---|---|
Oleaceae | 2 |
Hippocastanaceae | 2 |
Asteraceae | 1 |
Hydrangeaceae | 1 |
Aceraceae | 1 |
Fabaceae | 1 |
Solanaceae | 1 |
Amaranthaceae | 1 |
Apocynaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL54909 |
CHEMBL1613842
(1)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL54909 |
CHEMBL2114784
(1)
|
1 / 1 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | CHEMBL54909 |
CHEMBL950605
(1)
|
0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | CHEMBL54909 |
CHEMBL2341285
(1)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL54909 |
CHEMBL1614158
(2)
|
0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | CHEMBL54909 |
CHEMBL2341282
(1)
|
0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL54909 |
CHEMBL2341286
(1)
|
1 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL54909 |
CHEMBL1614027
(1)
|
0 / 1 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL54909 |
CHEMBL1008496
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL54909 |
CHEMBL1614458
(2)
|
0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | CHEMBL54909 |
CHEMBL2341283
(1)
|
1 / 2 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL54909 |
CHEMBL1794486
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL54909 |
CHEMBL2114780
(1)
|
0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | CHEMBL54909 |
CHEMBL2341287
(1)
|
0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL54909 |
CHEMBL2114788
(1)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL54909 |
CHEMBL1613808
(2)
|
0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | CHEMBL54909 |
CHEMBL2341284
(1)
|
0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL54909 |
CHEMBL1613910
(2)
CHEMBL1614227
(1)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL54909 |
CHEMBL1614038
(2)
|
2 / 2 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL54909 |
CHEMBL1614240
(1)
|
0 / 0 |
P55210 | Caspase-7 | C14 | CHEMBL54909 |
CHEMBL1613779
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL54909 |
CHEMBL1613777
(1)
|
1 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL54909 |
CHEMBL1794483
(1)
|
0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL54909 |
CHEMBL1737991
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL54909 |
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL54909 |
CHEMBL1614250
(1)
CHEMBL1614421
(2)
|
4 / 3 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL54909 |
CHEMBL1794536
(3)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL54909 |
CHEMBL1613914
(2)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL54909 |
CHEMBL1614364
(1)
|
1 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL54909 |
CHEMBL1614531
(1)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL54909 |
CHEMBL1614531
(1)
|
1 / 3 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL54909 |
CHEMBL2114738
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C105671 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | fraxetin results in decreased expression of BAX protein |
decreases expression
|
protein |
15996779
|
C105671 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | fraxetin results in decreased activity of CASP3 protein |
decreases activity
|
protein |
15996779
|
C105671 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | fraxetin results in decreased activity of CASP9 protein |
decreases activity
|
protein |
15996779
|
C105671 | 847 |
CAT
|
catalase (EC:1.11.1.6) | fraxetin inhibits the reaction [Rotenone results in increased expression of and results in increased activity of CAT protein] |
decreases reaction
/ increases activity / increases expression |
protein |
15904944
|
C105671 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | fraxetin affects the localization of CYCS protein |
affects localization
|
protein |
15996779
|
C105671 | 6648 |
SOD2
IPOB MNSOD MVCD6 |
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) | fraxetin inhibits the reaction [Rotenone results in increased expression of and results in increased activity of SOD2 protein] |
decreases reaction
/ increases activity / increases expression |
protein |
15904944
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|